{"transactions":[{"id":937078,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69238,"kind":"person","name":"Kirk Allan","position":1,"cik":"0001995409","reported_name":"Kirk Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-16T22:00:07.000Z","date":"2026-01-10","kind":"exercise","planned":false,"acquired":false,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3430},"source":{"system":"sec-edgar","filing":"0001193125-26-015487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000119312526015487/ownership.xml","form_type":"4"}},{"id":937077,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69238,"kind":"person","name":"Kirk Allan","position":1,"cik":"0001995409","reported_name":"Kirk Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T22:00:07.000Z","date":"2026-01-10","kind":"exercise","planned":false,"acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."}],"balance_after":3430,"source":{"system":"sec-edgar","filing":"0001193125-26-015487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000119312526015487/ownership.xml","form_type":"4"}},{"id":1304234,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69238,"kind":"person","name":"Kirk Allan","position":1,"cik":"0001995409","reported_name":"Kirk Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-13T22:30:03.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the total restricted stock units will vest on January 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the total restricted stock units will vest on January 10, 2026."}],"balance_after":3430,"derivative":{"underlying":"Common Stock","underlying_shares":3430},"source":{"system":"sec-edgar","filing":"0000950170-25-004914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025004914/ownership.xml","form_type":"4"}},{"id":1304233,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69238,"kind":"person","name":"Kirk Allan","position":1,"cik":"0001995409","reported_name":"Kirk Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T22:30:03.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":30870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 30,870 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026."}],"balance_after":30870,"derivative":{"exercise_price":4.04,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":30870},"source":{"system":"sec-edgar","filing":"0000950170-25-004914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025004914/ownership.xml","form_type":"4"}},{"id":1767078,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69238,"kind":"person","name":"Kirk Allan","position":1,"cik":"0001995409","reported_name":"Kirk Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-03T20:17:59.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":150437,"price":1.55,"value":233177.35,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on October 2, 2024 and with respect to 75,218 shares on October 2, 2025."}],"balance_after":150437,"derivative":{"exercise_price":1.55,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":150437},"source":{"system":"sec-edgar","filing":"0001209191-23-051456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000120919123051456/doc4.xml","form_type":"4"}}]}